Stocks and Investing Stocks and Investing
Tue, August 3, 2021
Mon, August 2, 2021
Sun, August 1, 2021
Fri, July 30, 2021

Salveen Richter Downgraded (AGIO) to Strong Sell and Decreased Target to $39 on, Jul 30th, 2021


Published on 2024-10-27 17:26:15 - WOPRAI
  Print publication without navigation


Salveen Richter of Goldman Sachs, Downgraded "Agios Pharmaceuticals, Inc." (AGIO) to Strong Sell and Decreased Target from $58 to $39 on, Jul 30th, 2021.

Salveen has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021


This is the rating of the analyst that currently disagrees with Salveen


  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $65 on, Friday, April 30th, 2021